Nanostructured chemiresistive gas sensors for medical applications

Abstract

Treating diseases at their earliest stages significantly increases the chance of survival while decreasing the cost of treatment. Therefore, compared to traditional blood testing methods it is the goal of medical diagnostics to deliver a technique that can rapidly predict and if required non‐invasively monitor illnesses such as lung cancer, diabetes, melanoma and breast cancer at their very earliest stages, when the chance of recovery is significantly higher. To date human breath analysis is a promising candidate for fulfilling this need. Here, we highlight the latest key achievements on nanostructured chemiresistive sensors for disease diagnosis by human breath with focus on the multi‐scale engineering of both composition and nano‐micro scale morphology. We critically assess and compare state‐of‐the‐art devices with the intention to provide direction for the next generation of chemiresistive nanostructured sensors.